|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Dietary soy modulation of biochemical parameters in DMBA -induced mammary tumors 显示文摘 | Gallo D Ferrandina G Giacomelli S | 2002 | Cancer Lett2002，186，1： | 1 |
| 2 | Expression of cyclooxygenase-2 (COX-2), receptors for estrogen ( ER), and progesterone (PR) , p53, ki67, and neu pro- tein in endometrial cancer显示文摘 | Ferrandina G Ranelletti FO Gallotta V | 2005 | Gynecol Oncol2005，98，： | 1 |
| 3 | Increased cy- clooxygenase - 2 ( COX - 2 ) expression is associated withchemotherapy resistance and outcome in ovarian cancer pa- tients显示文摘 | Ferrandina G Lauriola L Zannoni GF | 2002 | Ann Onco12002，13，8： | 1 |
| 4 | GLUT-1 expression in ovarian carcinoma: association with survival and response to chemotherapy 显示文摘 | Cantuaria G Fagotti A Ferrandina G | 2001 | Cancer2001，92，5： | 1 |
| 5 | Sonographic features of decidualized ovarian endometriosis suspicious for malignancy显示文摘 | Fruscella E Testa AC Ferrandina G | 2004 | Ultrasound Obstet Gynecol2004，24，5： | 1 |
| 6 | Cyclooxy- genase - 2 ( Cox - 2) expression and resistance to platinum versus platinum/paclitaxel containing chemotherapy in ad- vanced ovarian cancer 显示文摘 | Ferrandina G Ranelletti FO Martinelli E | 2006 | BMC Cancer2006，6，： | 1 |
| 7 | Gynecological malignancies in elderly patients : is age 70 a limit to standarddose chemotherapy? An Italian retrospective toxicity multicentric study显示文摘 | Ceccaroni M D'Agonstino G Ferrandina G | 2002 | Hynecol Oncol2002，85，3： | 1 |
| 8 | Evaluation ofpemetrexed (alimta,ly231514) as second-linechemotherapy in persistent or recurrent carcinoma of thecervix: the cervix 1 study of the mito (multicentre italiantrials in ovarian cancer and gynecologic malignancies)group 显示文摘 | Lorusso D Ferrandina G Pignata S | 2010 | Ann Oncol2010，21，1： | 1 |
| 9 | Phase trial of gemc-itabine compared with pegylated liposomal doxorubicin in progressiveor recurrent ovarian oancer显示文摘 | Ferrandina G Ludovisi M Lomsso D | 2008 | J Clin Oncol2008，26，6： | 1 |
| 10 | Increased cyclooxygenase -2 (COX-2) expression is associated with chemotherapy resistance and outcome in ovarian cancer patients显示文摘 | Ferrandina Lanriola L Zannoni G | 2002 | Ann Oncol2002，13，8： | 1 |
| 11 | Neoajuvant chemoradiation followed by radical hysterectomy in FIGO stage ⅢB cervical cancer:feasibility,complications,and clinical outcome显示文摘 | Fanfani F Fagotti A Ferrandina G | 2009 | Int J Gynecol Cancer2009，19，6： | 1 |
| 12 | Increased cyelooxygenase-2 expression is associated with chemotherapy resistance and poor survival in cervical cancer patients显示文摘 | Ferrandina G Lauriola L Distefano MG | | 0，，： | 1 |
| 13 | Role of cmnorhidities in locally advanced cervical cancer patients administered preoperative chemoradiation: impact on outcome and treatment-related complications显示文摘 | Ferrandina G Lucidi A Paglia A | 2012 | EurJSurgOncol2012，38，3： | 1 |
| 14 | Neoadjuvantchemoradia-tion followed by radical hysterectomy in FIGO Stage IIIBcervicalcancer: feasibility, complications, and clinicaloutcome显示文摘 | Fanfani F Fagotti A Ferrandina G | 2013 | Int J Gyne-col Cancer2013，19，6： | 1 |
| 15 | Expression of cyclooxygenase-2 (COX-2) in non-neoplastic and neoplastic vulvar epithelial lesions显示文摘 | FERRANDINA G RANELLETTI F O SALUTARI V | 2004 | Gynecol Oncol2004，92，2： | 1 |
| 16 | Increased cyclooxygenase-2(COX-2) expression is associated with chemotherapy resistance and outcome in ovarian cancer patients显示文摘 | Ferrandina G Lauriola L Zannoni GF | 2002 | Ann Oncol2002，13，8： | 1 |
| 17 | Ovarian cancer pa-tients with ” node - positive - only” stage DIC disease have a morefavorable outcome than stage DIalB 显示文摘 | Ferrandina G Scambia G Legge F | 2007 | Gynecol Oncol2007，107，1： | 1 |
| 18 | Squamous cell carcinoma antigen in follow-up of cervical cancer treated with radiotherapy : evaluation of cost-effectiveness 显示文摘 | Forni F Ferrandina G Deodato F | 2007 | Int J Radiat Oncol Biol Phys2007，69，4： | 1 |
| 19 | Celecoxib modulates the expression of cyclooxygenase-2,ki67,apoptosis-related marker,and microvessel density in human cervical cancer: a pilot study显示文摘 | Ferrandina G Ranelletti FO Legge F | 2003 | Clin Cancer Res2003，9，12： | 1 |
| 20 | Tamoxifen modulates the expression of Ki67,apoptosis,and microvessel density in cervical cancer显示文摘 | Ferrandina G Ranelletti F O Larocca L M | 2001 | Clin Cancer Res2001，7，9： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员